These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9023661)

  • 41. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.
    Jung R; Fish DN; Obritsch MD; MacLaren R
    J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa].
    Anan N; Toba S; Ito A; Nakamura R; Tsuji M
    Jpn J Antibiot; 2011 Aug; 64(4):203-16. PubMed ID: 22066345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of aztreonam, cefotaxime, ceftazidime and imipenem combined with ciprofloxacin against gram-negative bacilli and compared with amikacin combinations against Pseudomonas aeruginosa.
    Díez Enciso M
    Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):90-2. PubMed ID: 1907544
    [No Abstract]   [Full Text] [Related]  

  • 46. In Vitro Activity of Fosfomycin in Double and Triple Combinations with Imipenem, Ciprofloxacin and Tobramycin Against Multidrug-Resistant Escherichia coli.
    El-Wafa WMA; Ibrahim YM
    Curr Microbiol; 2020 May; 77(5):755-761. PubMed ID: 31919670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
    Flynn CM; Johnson DM; Jones RN
    J Chemother; 1996 Dec; 8(6):411-5. PubMed ID: 8981179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
    Bernabeu-Wittel M; Pichardo C; García-Curiel A; Pachón-Ibáñez ME; Ibáñez-Martínez J; Jiménez-Mejías ME; Pachón J
    Clin Microbiol Infect; 2005 Apr; 11(4):319-25. PubMed ID: 15760430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
    Gholipourmalekabadi M; Sameni M; Hashemi A; Zamani F; Rostami A; Mozafari M
    Burns; 2016 Feb; 42(1):131-140. PubMed ID: 26603913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1988 May; 36(5):472-6. PubMed ID: 3136428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.
    Fass RJ; Barnishan J; Ayers LW
    J Antimicrob Chemother; 1995 Aug; 36(2):343-53. PubMed ID: 8522464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics.
    Trautmann M; Zick R; Rukavina T; Cross AS; Marre R
    J Antimicrob Chemother; 1998 Feb; 41(2):163-9. PubMed ID: 9533457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong.
    Ling TK; Ying CM; Lee CC; Liu ZK
    Med Princ Pract; 2005; 14(5):338-41. PubMed ID: 16103700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].
    Blahová J; Hupková-Lesická M; Králiková K; Krcméry V; Kubonová K
    Cas Lek Cesk; 1997 Mar; 136(5):154-6. PubMed ID: 9221190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
    Petersen PJ; Jacobus NV; Weiss WJ; Testa RT
    Antimicrob Agents Chemother; 1991 Jan; 35(1):203-7. PubMed ID: 1901698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
    Vitkauskiene A; Sakalauskas R; Dudzevicius V
    Medicina (Kaunas); 2003; 39(3):254-9. PubMed ID: 12695638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus.
    Bergogne-Berezin E; Joly-Guillou ML
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():35-9. PubMed ID: 3546246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
    Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.